about
Lateral transfer of genes and gene fragments in Staphylococcus extends beyond mobile elementsReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsMechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolonesProgress toward a Staphylococcus aureus vaccineInnovative qPCR using interfacial effects to enable low threshold cycle detection and inhibition relief.Molecular Basis of Vancomycin Dependence in VanA-Type Staphylococcus aureus VRSA-9Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureusStrain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of InfectionImpact of Staphylococcus aureus on pathogenesis in polymicrobial infections.Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathwaysHigher incidence of perineal community acquired MRSA infections among toddlers.Tn1546 is part of a larger plasmid-encoded genetic unit horizontally disseminated among clonal Enterococcus faecium lineages.Mobile genetic elements of Staphylococcus aureus.ε/ζ systems: their role in resistance, virulence, and their potential for antibiotic development.Comparative genomics of community-acquired ST59 methicillin-resistant Staphylococcus aureus in Taiwan: novel mobile resistance structures with IS1216V.Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance.In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens.Integrated Multilevel Surveillance of the World's Infecting Microbes and Their Resistance to Antimicrobial Agents.Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009Wounds, functional disability, and indwelling devices are associated with cocolonization by methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in southeast Michigan.Major families of multiresistant plasmids from geographically and epidemiologically diverse staphylococci.Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.Glycopeptide resistance in gram-positive cocci: a review.Genomic analysis of the emergence of vancomycin-resistant Staphylococcus aureusTransferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalisThe posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus.Intrinsic and acquired resistance mechanisms in enterococcus.Vaccination with a UV-irradiated genetically attenuated mutant of Staphylococcus aureus provides protection against subsequent systemic infection.Targeting bacterial membrane function: an underexploited mechanism for treating persistent infectionsEpidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study.The Staphylococcus aureus thiol/oxidative stress global regulator Spx controls trfA, a gene implicated in cell wall antibiotic resistance.Screening for Intestinal Colonization with Vancomycin Resistant Enterococci and Associated Risk Factors among Patients Admitted to an Adult Intensive Care Unit of a Large Teaching HospitalRapid detection of Staphylococcus aureus strains with reduced susceptibility to vancomycin by isothermal microcalorimetry.Compensation of fitness costs and reversibility of antibiotic resistance mutations.Emergence and spread of cfr-mediated multiresistance in staphylococci: an interdisciplinary challenge.Peptidoglycan hydrolases-potential weapons against Staphylococcus aureusCombating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.Staphylococcus aureus Penicillin-Binding Protein 2 Can Use Depsi-Lipid II Derived from Vancomycin-Resistant Strains for Cell Wall Synthesis.Resistance of Staphylococcus aureus to antimicrobial agents in Ethiopia: a meta-analysis.
P2860
Q24625503-FE20EC38-3EFF-4410-9292-0FBAEC7E7F03Q24646677-A076D445-CE3D-4BE0-88CC-CFA814CBA868Q26828604-98B13895-15D1-4037-9613-3933F946B2E2Q26829702-108D1798-B25B-42A7-BBF7-D1F8521821C3Q27344266-E33CBF9C-127D-4256-B5F4-47563B70D84AQ27664123-369B1716-7375-4894-BD1A-B2113D10FF16Q28478770-64169B16-745F-455F-A8AA-A8A75B77166FQ28546694-CF54261F-FD23-4DD6-A56C-7425A9530598Q33602984-C97E274D-2BC5-4811-B5D4-F4286777DECAQ33696380-2CB55C64-D0B8-4D12-9A8F-123958D2F22BQ33963770-98611CCC-D438-458C-81F8-AC67E7852D88Q34059907-F58C24C4-FFC6-4544-937F-10161BA18EEEQ34060371-6B67DB23-38F4-44C6-83F1-985E7B60D078Q34089037-7A845697-0F4A-43C6-8755-ACDD260DD170Q34206489-805547D2-4AB7-458E-BA74-E6DEC7A96A41Q34447722-4A4B59D1-E528-437F-AB0A-7305CEF7748DQ34737155-7F903EEF-1BB2-4AC6-943A-F6ADAD93D173Q35005092-0F823BB2-CC49-4D14-8A8F-1DE52084CAF5Q35066011-EC47FC82-EBD0-4818-B55A-2EF7E7955518Q35176294-6F4332AF-0862-452D-8FF8-AAF480C5949BQ35545363-F81A24C4-3285-4A30-A531-D4BA21572ACCQ35746851-79D5F961-73D4-4F3F-94B6-0E54D920EF75Q35941296-809E5BA9-7949-4175-8FA7-220E32C21637Q36072225-21F32934-5D0A-4142-8437-32F01106615EQ36073633-BE142690-7D05-46EA-A1C4-534E1DCBA861Q36086317-924BF6BA-8DDD-4851-8433-C3D31C698EFAQ36086420-B8FAA2DB-9F4E-4B4D-AD5C-85954E14012FQ36362547-5F3333B8-424E-4B34-9697-B43C7632B1A7Q36368669-AB11C248-3009-4B19-9F36-5ACF825CFF01Q36393640-E8137063-09F8-4DEE-81CB-9E9F094B0DC2Q36505351-63A8C6C8-D4A6-4E16-B6AF-27D3337F6885Q36969735-169C1974-EC81-4FEC-B7C2-1B5B4DE0E732Q37352928-828FD73D-E2B3-4AB2-B903-AF4F6356F546Q37546679-7C580A82-E3EA-48DC-AF2F-28F9A196DC79Q37696851-DCEBB2FB-D748-4F3B-A615-EAE2DF887040Q37921295-4A360B6A-43B6-4586-B6A0-1CB59B32CD17Q38053102-54FB22A0-4646-4767-9A68-F4255A341820Q38137920-E4C460C2-CA33-42B4-9B69-43DCEA10873CQ38313962-13E7633F-35E0-48E8-BD56-6E92469A33E2Q38602847-AA641926-4F6E-4060-AFB1-F2E9EF22F2B8
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
VanA-type vancomycin-resistant Staphylococcus aureus.
@en
VanA-type vancomycin-resistant Staphylococcus aureus.
@nl
type
label
VanA-type vancomycin-resistant Staphylococcus aureus.
@en
VanA-type vancomycin-resistant Staphylococcus aureus.
@nl
prefLabel
VanA-type vancomycin-resistant Staphylococcus aureus.
@en
VanA-type vancomycin-resistant Staphylococcus aureus.
@nl
P2860
P356
P1476
VanA-type vancomycin-resistant Staphylococcus aureus.
@en
P2093
Bruno Périchon
Patrice Courvalin
P2860
P304
P356
10.1128/AAC.00346-09
P407
P577
2009-06-08T00:00:00Z